MYD88 L265P mutation in Waldenstrom macroglobulinemia-Reference-Cited by-同舟云学术

MYD88 L265P mutation in Waldenstrom macroglobulinemia

Published:2013-05-30 Issue:22 Volume:121 Page:4504-4511
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Poulain Stéphanie¹²,Roumier Christophe²,Decambron Audrey¹,Renneville Aline²,Herbaux Charles³⁴,Bertrand Elisabeth³,Tricot Sabine¹,Daudignon Agnès¹,Galiègue-Zouitina Sylvie³,Soenen Valerie²,Theisen Olivier¹,Grardel Nathalie²,Nibourel Olivier²,Roche-Lestienne Catherine²³,Quesnel Bruno³⁴,Duthilleul Patrick¹,Preudhomme Claude²³,Leleu Xavier³⁴

Affiliation:

1. Department of Hematology-Immunology-Cytogenetic, Centre Hospitalier, Valenciennes, France;

2. Laboratory of Hematology, Biology and Pathology Center, Centre Hospitalier Régional Universitaire, Lille, France;

3. INSERM U837, Team 3, Cancer Research Institute of Lille, Lille, France; and

4. Service des Maladies du Sang, Hôpital Huriez, Centre Hospitalier Régional Universitaire, Lille, France

Abstract

Key Points The MYD88 locus is altered in 91% of patients with WM. MYD88 might be new target for therapeutic in WM.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/121/22/4504/1366341/4504.pdf

Reference32 articles.

1. Oncogenic MYD88 mutation drives Toll pathway to lymphoma.;Jeelall;Immunol Cell Biol,2011

2. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling.;O’Neill;Nat Rev Immunol,2007

3. Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound.;Loiarro;J Leukoc Biol,2007

4. Oncogenically active MYD88 mutations in human lymphoma.;Ngo;Nature,2011

5. Waldenström macroglobulinemia: 2011 update on diagnosis, risk stratification, and management.;Gertz;Am J Hematol,2011

Cited by 196 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Waldenstrom Macroglobulinemia;Reference Module in Biomedical Sciences;2024

2. New developments in the diagnosis and characterization of Waldenström’s macroglobulinemia;Expert Review of Hematology;2023-11-02

3. Clonal Relationship and Mutation Analysis in Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia Associated With Diffuse Large B-cell Lymphoma;HemaSphere;2023-11

4. Current approach to Waldenström macroglobulinemia;Blood Reviews;2023-11

5. MYD88 Wild Type in IgM Monoclonal Gammopathies: From Molecular Mechanisms to Clinical Challenges;Hemato;2023-09-13